Nedosiran

• Target :

  Others|||Dehydrogenase

• Related Pathways :

  Metabolism|||Others

• Bioactivity :

  Nedosiran (DCR-PHXC) is a GalNAc-dsRNA conjugate designed for RNA interference (RNAi) targeting lactate dehydrogenase (LDH) . It serves as a potential therapeutic option for patients with primary hyperoxaluria (PH) and end-stage renal disease (ESRD) .

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2266591-83-5